Ticker
AVTXCompany Name
AVALO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ 9.66 | $ 104.57M | 1 | 10.83M |
3/31/2025 | $ 11.66 | $ 122.61M | 1 | 10.51M |
12/31/2024 | $ 12.47 | $ 133.03M | 1 | 10.67M |
9/30/2024 | $ 2.03 | $ 21.08M | 1 | 10.39M |
6/30/2024 | $ -13.16 | $ -13.61M | 1 | 1.03M |
3/31/2024 | $ -108.83 | $ -112.54M | 1 | 1.03M |
12/31/2023 | $ 7.06 | $ 7.3M | 1 | 1.03M |
9/30/2023 | $ 18.33 | $ 14.7M | 1 | 801.59K |
6/30/2023 | $ -82.6 | $ -6.97M | 1 | 84.37K |
3/31/2023 | $ -113.94 | $ -6.27M | 1 | 55K |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for AVALO THERAPEUTICS INC is calculated as follows: Equity [ $ 38.57M ] / (Shares WA [ 26.01K ] * Share Factor [ 1 ])
(=) BVPS [ $ 1.48K ]
Minimum
Dec 31, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.99K |
---|---|
min | $ -30.1 |
max | $ 46.62 |
average | $ 10.29 |
median | $ 6.05 |
std | $ 12.43 |